Armata Pharmaceuticals Inc

ASE:ARMP   2:45:21 PM EDT
3.62
-0.02 (-0.41%)
Officer Changes, Earnings Announcements

Armata Pharmaceuticals Announces Second Quarter Results And Provides General Corporate Update

Published: 08/12/2021 22:16 GMT
Armata Pharmaceuticals Inc (ARMP) - Armata Pharmaceuticals Announces Second Quarter Results and Provides General Corporate Update.
Armata Pharmaceuticals Inc - Todd R. Patrick, Ceo, Has Retired From the Company.
Armata Pharmaceuticals Inc - Brian Varnum, Phd, Former President and Chief Development Officer, Has Been Appointed the Company's New Ceo.
Armata Pharmaceuticals Inc - Qtrly Loss per Share $0.25.
Revenue is expected to be $1.08 Million
Adjusted EPS is expected to be -$0.26

Next Quarter Revenue Guidance is expected to be $1.1 Million
Next Quarter EPS Guidance is expected to be -$0.26

More details on our Analysts Page.